Kirill A. Martemyanov

University of Florida

NIH Rank #1048
  • R01 Holder
  • Top 10% Funded
  • Multi-Institutional
  • Early Career

NIH Funding · FY2024

Total Funding
$5.2M
Fiscal year 2024
Grants Awarded
8
Active NIH grants
National Rank
#1,048
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $5.2M across 8 grants · National rank #1048.

Top grants by award amount

Kirill A. Martemyanov's NIH grant portfolio, ranked by award amount.

  • 2R01DA048036-07R01
    Molecular genetic mechanisms of opioid receptor signaling
    $800.6K
    award amount
  • 1R01DA061771-01R01
    Pharmacological targeting of nascent modulators of opioid signaling
    $772.8K
    award amount
  • 1R01DA056414-01A1R01
    Trans-synaptic control of GPCR signaling in opioid reward
    $666.6K
    award amount
  • 5R01MH105482-10R01
    Orphan Receptors in Regulation of Neuronal G Protein Signaling
    $640.2K
    award amount
  • 5R01NS128039-02R01
    Architecture of inhibitory G protein signaling in the hippocampus
    $632.5K
    award amount
  • 2R01EY028033-07A1R01
    Molecular Basis of Photoreceptor Wiring
    $607.3K
    award amount
  • 5R01EY018139-18R01
    Molecular Organization of the First Visual Synapse
    $583.1K
    award amount
  • 5R01EY034339-03R01
    Structural landscape of photoreceptor synapses
    $483K
    award amount

Affiliations

Institutions that have administered grants for Kirill A. Martemyanov.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Florida
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #1048
  7. 2024
    Entered Top 25% Nationally
    Ranked #1048
  8. 2024
    Entered Top 10% Nationally
    Ranked #1048
  9. 2024
    Multi-Institutional Research
    Awards at 3 institutions